SlideShare a Scribd company logo
Curriculum Vitae
Dr. Meti G Y
R &D Assistant manager, R L Fine Chem pvt ltd Yelahanka Bangalore
Career Objective:
To achieve a challenging position in a desired organization, where I can prove my capabilities and
strength in conjunction with organization’s goals and objectives.
Date of birth 12/10/1971
Age
44
Nationality Indian
Marital Status Married
Address for correspondence
Dr. Gangadhar Y. Meti
c/o, Ashwathamma
#21, first floor, 2nd B cross
Chikkabommasandra, GKVK post
Yelahanka new town,
Bangalore 560065 E-mail: gymeti@rediffmail.com
Dr.gym1971@gmail.com
State: Karnataka Mobile: +91-9739422694, +91-8762191241
Job Profile :
Having more than 12 years of Experience in Process R&D
 R L Fine Chem., Yelahanka, Bangalore working as a R&D Assistant manager (Since Dec 2013)
 Dept of Chemistry of Karnataka University Dharwad as a UGC Project fellow (June 2010- Jan
2013)
 Jubilant Organosys Ltd. Mysore, worked as a Research Scientist in Process R & D.( Nov 2003 to
May 2010)
 R L Fine Chem Yelahanka, Bangalore, worked as a R&D Chemist (Feb 2001–Oct 2003).
 Recon Ltd Bangalore, worked as a Trainee R&D Chemist. (July 1997-Dec-1997).
 Shri Kalidas Composite Pre-University College Badami, worked as a part time Lecturer. (Aug
1998 to Sept 1999)
Academic Credentials:
 Doctor of Philosophy PhD in Organic Chemistry May 2011-Mar 2015 Karnatak University,
Dharwad, India
 Junior Research Fellow (JRF) in the UGC funded Major Research Project 2010-2013
 Master of Science (M. Sc.) in Chemistry / Organic Chemistry (First Class), from June 1995-
May, 1997 Karnatak University, Dharwad, India
 Bachelor of Science (B.Sc.) in Chemistry, Physics, Mathematics (Second Class), June 1992 –
May 1995, Karnatak University, Dharwad, India.
 Post graduate Diploma in IPR (Waiting for marks card, with first class) June 2012- Sept 2015
from K S O University Mysore
Research Highlights :
I was involved in Synthetic Organic Chemistry Research during my Ph.D. course. Twenty of my research
samples have been selected for anti cancer screening (against 60 cancer cell lines) at national cancer
Institute, a daughter organization of National Institute of Health, USA. Among these samples, three have
been screened for five dose testing level.
Responsibilities:
 Responsible for planning and executing developmental activities related to improvement in
quality/efficiency/process simplification etc., of existing products as well as development of process
for new products.
 Applied six sigma concepts in the process development of Atomxetine hydrochloride,
Paliperidone palmitate, Olmesartan and Azilsartan medoxomil.
 Technology transfer from lab scale to kilo/pilot plant scale and commercialization through appropriate
validation, scale up and optimization studies.
 Developing non-infringing routes for the existing/new molecules.
 Online literature search, infringement analysis & suggestion and interpreting the claims in patents.
 Updating the literature for the particular project at regular interval.
 Interpretation of intermediate/finished product by IR, NMR, Mass, GC and HPLC.
 Preparing Development report, Impurity profiling, Technology transfer document and Polymorphs.
 Selection of route, Cost reduction, minimization of waste and conforming process norms.
 Documentation, safe working and good housekeeping.
 Effective co-ordination with process engineering and production department, while transferring the lab
developed technologies.
Projects Handled:
 Antidepressents like Bupropion, Citalopram hydrobromide etc.,
 Antipsychotic like Risperidone, paliperidone, Paliperidone palmitate, Ziprasidone.
 Antibiotic like Azithromycin.
 Antispasmodic like Pinaverium bromide.
 Analgesic like Tramadol etc.
 Antihistamine like Doxylamine Citrate etc.
 Norepinephrine reuptake inhibitor (NRI) or Adrenergic reuptake inhibitor (ARI) like
Atomxetine hydrocloride
 Antihypertensive like Olmesartan and Azilsartan medoxomil.
Training programs:
 Safety, Health and Environment training program periodically.
 GMP and GLP training program periodically.
 Six sigma-Designs of Experiments.
 Intellectual property rights (patents only).
 Interpersonal relationship.
Summary of Skills:
 Patent search, Patent analysis, and literature search
 Optimization, validation, scale up and Technology transfer
 Auto clave reactions and Moisture sensitive reactions
 Crystallization techniques
 Impurity preparation.
 Column chromatography
Achievements:
 Successfully validated and implemented the “non infringing process route” to commercial plant for
Bupropion, Risperidone, Ziprasidone, Azithromycin.
 Gained commanding knowledge on Intellectual Property Rights (patents only)
Publications:
 Synthesis of biphenyl derivatives as ACE and α-amylase inhibitors, Gangadhar Yamanappa
Meti, Ravindra Ramappa Kamble, Dharesh Bhimaraya Biradar, Sheetal Babu Margankop, Med.
Chem. Res. (Springer), 2013, 22:5868-77.
 An efficient synthesis, X-ray and spectral characterization of biphenyl derivatives, G. Y. Meti, R.
R Kamble, D. B. Biradar, T. Taj, T. Gireesh, I. M Khazi, S. T. Vaidyanathan, R. Mohandoss, B.
Sridhar, and V. Parthasarathy, J. Chem. Sci (Springer) 123, 2011, 393–401.
 Synthesis of 4H-pyrido [1,2-a]pyrimidin-4-one derivatives as Anti-inflammatory agents,
Gangadhar Meti, Pramod Kattimani, Ravindra Kamble, H. C. Devarajegowda, Mahadev Kumbar,
D. Jagadeesh Prasad, World. J. Pharm. Sci. 2015, 3, 277-287.
 2-[4-(Morpholin-4-ylmethyl)phenyl]benzonitrile, Gangadhar Y. Meti, R. R Kamble, A. J. Ravi, H.
K. Arunkashi and H. C. Devarajegowda, Acta Cryst. 2013, E69, o129.
 5-{4-[(5-Benzyl-2H-tetrazol-2-yl)-methyl]biphenyl-2-yl}-1H-tetrazole monohydrate, Gangadhar Y.
Meti, S. Jayaseelan, R. R. Kamble, Atukuri Dorababu and H. C. Devarajegowda, Acta Cryst.
2013. E69, o743–o744.
 Bis-Tetrazole Derivatives of Biphenyls: Molecular Docking, Synthesis and ACE Inhibition Studies,
Gangadhar Y. Meti, Atulkumar A. Kamble, Kuramkote S. Devaraju, Bodhaguru M. Harish and
Ravindra R. Kamble, Bioorg. Med. Chem Letters (Elsevier) (Communicated).
 Synthesis and anticancer activity of 6-chloro-5-(2-chloroethyl)-1,3-dihydro- 2H-indol-2-one
derivatives.E J Medi Che (Communicated). Gangadhar Y. Meti, Ravindra R. Kamble, Pramod
P. Kattimani, Atulkumar A. Kamble, T. M. Girish, H. C. Devarajegowda.
 Facile Synthesis of novel quinoline derivatives as anticancer agents, S. B. Margankop, R. R.
Kamble, J. Hoskeri, D. J. Prasad, G. Y. Meti, Med. Chem. Res. (Springer), DOI No.
10.1007/s00044-013-0855-2.
 Synthesis of novel imidazo [2,1-b][1,3,4] thiadiazoles appended to sydnone as anticancer agents,
Tegginamath Gireesh, Ravindra R. Kamble, Tasneem Taj, Pramod P. Kattimani, Gangadhar Y.
Meti, Med. Chem. Res. (Springer), 2013, 22:4367-75.
 Expedient synthesis of benzimidazoles from amides, Pramod P. Kattimani, Ravindra R. Kamble,
Gangadhar Y. Meti, RSC.Adv, 2015,5, 29447-29455.
 Ring Opening of Tetrazole via Unusual Vilsmeir-Haack Reaction Forming Novel Triazenes.
Atukuri Dorababu, Ravindra R. Kamble, H. C. Devarajegowda and Gangadhar Y. Meti. Letters in
Organic Chemistry, 2015, 12, 122-128.
 Synthesis of Novel 1,2,4-Triazole Derivatives as Antimicrobial Agents via the Japp-Klingemann
Reaction: Investigation of Antimicrobial Activities. Journal of Chemistry, (2013),
http://dx.doi.org/10.1155/2013/909706,Tasneem Taj, Ravindra R. Kamble, Atukuri Dorababu, and
Gangadhar Y. Meti.
 Electronic Effect of Substituents Present on Carbonyl Compounds: Analysis of Product Formation
in One-Pot Synthesis of 1, 3, 4-thiadiazole Ring. ACSj.18204, Sheetal B. Marganakop, Ravindra
R. Kamble, Gangadhar Y. Meti and Mahadev N. Kumbar
References: Need basis

More Related Content

What's hot

Umesh Resume(Int)
Umesh Resume(Int)Umesh Resume(Int)
Umesh Resume(Int)
umesh A
 
Ki Ttu
Ki TtuKi Ttu
PhD viva slides
PhD viva slidesPhD viva slides
PhD viva slides
Gilish Jose
 
cv 20 jan15
cv 20 jan15cv 20 jan15
cv 20 jan15
gitanjali sharma
 
Physical and Structural Characterization of Biofield Treated Imidazole Deriva...
Physical and Structural Characterization of Biofield Treated Imidazole Deriva...Physical and Structural Characterization of Biofield Treated Imidazole Deriva...
Physical and Structural Characterization of Biofield Treated Imidazole Deriva...
albertdivis
 
Ria Pal_Resume
Ria Pal_ResumeRia Pal_Resume
Ria Pal_Resume
Ria Pal
 
Bio data- kundan
Bio data- kundanBio data- kundan
Bio data- kundan
Dr Kundan Prasad
 
Chemical engineering
Chemical engineeringChemical engineering
Chemical engineering
ssuser812422
 
ppt poster
ppt posterppt poster
ppt poster
Srijal Patel
 
QSAR Modeling of Bisbenzofuran Compounds using 2D-Descriptors as Antimalarial...
QSAR Modeling of Bisbenzofuran Compounds using 2D-Descriptors as Antimalarial...QSAR Modeling of Bisbenzofuran Compounds using 2D-Descriptors as Antimalarial...
QSAR Modeling of Bisbenzofuran Compounds using 2D-Descriptors as Antimalarial...
ijtsrd
 
Wanda figueroa 29nov2011
Wanda figueroa 29nov2011Wanda figueroa 29nov2011
Wanda figueroa 29nov2011
Programa_BRIC
 
Biofield Treatment Impact on 1,2,4-Triazole
Biofield Treatment Impact on 1,2,4-TriazoleBiofield Treatment Impact on 1,2,4-Triazole
Biofield Treatment Impact on 1,2,4-Triazole
deeptimishra10
 
Anti oxidant activity of yucca gloriosa l ijrpp
Anti oxidant activity of yucca gloriosa l ijrppAnti oxidant activity of yucca gloriosa l ijrpp
Anti oxidant activity of yucca gloriosa l ijrpp
pharmaindexing
 
SURABHI SALONI
SURABHI SALONISURABHI SALONI
SURABHI SALONI
Surabhi saloni
 
updated resume Ananya
updated resume Ananyaupdated resume Ananya
updated resume Ananya
ananya bagchi
 
updated resume Ananya new
updated resume Ananya newupdated resume Ananya new
updated resume Ananya new
ananya bagchi
 
Biofield Treatment: A Potential Strategy for Modification of Physical and The...
Biofield Treatment: A Potential Strategy for Modification of Physical and The...Biofield Treatment: A Potential Strategy for Modification of Physical and The...
Biofield Treatment: A Potential Strategy for Modification of Physical and The...
albertdivis
 
Dr rahul-hajare cv-
Dr rahul-hajare cv-Dr rahul-hajare cv-
Dr rahul-hajare cv-
Rrahul Hajare (Post Doc., Ph.D)
 

What's hot (18)

Umesh Resume(Int)
Umesh Resume(Int)Umesh Resume(Int)
Umesh Resume(Int)
 
Ki Ttu
Ki TtuKi Ttu
Ki Ttu
 
PhD viva slides
PhD viva slidesPhD viva slides
PhD viva slides
 
cv 20 jan15
cv 20 jan15cv 20 jan15
cv 20 jan15
 
Physical and Structural Characterization of Biofield Treated Imidazole Deriva...
Physical and Structural Characterization of Biofield Treated Imidazole Deriva...Physical and Structural Characterization of Biofield Treated Imidazole Deriva...
Physical and Structural Characterization of Biofield Treated Imidazole Deriva...
 
Ria Pal_Resume
Ria Pal_ResumeRia Pal_Resume
Ria Pal_Resume
 
Bio data- kundan
Bio data- kundanBio data- kundan
Bio data- kundan
 
Chemical engineering
Chemical engineeringChemical engineering
Chemical engineering
 
ppt poster
ppt posterppt poster
ppt poster
 
QSAR Modeling of Bisbenzofuran Compounds using 2D-Descriptors as Antimalarial...
QSAR Modeling of Bisbenzofuran Compounds using 2D-Descriptors as Antimalarial...QSAR Modeling of Bisbenzofuran Compounds using 2D-Descriptors as Antimalarial...
QSAR Modeling of Bisbenzofuran Compounds using 2D-Descriptors as Antimalarial...
 
Wanda figueroa 29nov2011
Wanda figueroa 29nov2011Wanda figueroa 29nov2011
Wanda figueroa 29nov2011
 
Biofield Treatment Impact on 1,2,4-Triazole
Biofield Treatment Impact on 1,2,4-TriazoleBiofield Treatment Impact on 1,2,4-Triazole
Biofield Treatment Impact on 1,2,4-Triazole
 
Anti oxidant activity of yucca gloriosa l ijrpp
Anti oxidant activity of yucca gloriosa l ijrppAnti oxidant activity of yucca gloriosa l ijrpp
Anti oxidant activity of yucca gloriosa l ijrpp
 
SURABHI SALONI
SURABHI SALONISURABHI SALONI
SURABHI SALONI
 
updated resume Ananya
updated resume Ananyaupdated resume Ananya
updated resume Ananya
 
updated resume Ananya new
updated resume Ananya newupdated resume Ananya new
updated resume Ananya new
 
Biofield Treatment: A Potential Strategy for Modification of Physical and The...
Biofield Treatment: A Potential Strategy for Modification of Physical and The...Biofield Treatment: A Potential Strategy for Modification of Physical and The...
Biofield Treatment: A Potential Strategy for Modification of Physical and The...
 
Dr rahul-hajare cv-
Dr rahul-hajare cv-Dr rahul-hajare cv-
Dr rahul-hajare cv-
 

Similar to Dr.GYM-CV

RV-cv-pharm pdf
RV-cv-pharm pdfRV-cv-pharm pdf
RV-cv-pharm pdf
Venkatesham Rachakonda
 
CV_Dr R Ghosh
CV_Dr R GhoshCV_Dr R Ghosh
CV_Dr R Ghosh
RAMPRASAD GHOSH
 
brijesh(2)
brijesh(2)brijesh(2)
brijesh(2)
Brijesh Darji
 
TFadra-Khan Resume
TFadra-Khan ResumeTFadra-Khan Resume
TFadra-Khan Resume
Tazmeen Fadra-Khan
 
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi
 
CV_Hari Narayan Kushwaha
CV_Hari Narayan KushwahaCV_Hari Narayan Kushwaha
CV_Hari Narayan Kushwaha
Hari Narayan kushwaha
 
Resume....
Resume....Resume....
Cv dr-rahul- hajare jan- 2017
Cv  dr-rahul- hajare   jan- 2017Cv  dr-rahul- hajare   jan- 2017
Cv dr-rahul- hajare jan- 2017
Rrahul Hajare (Post Doc., Ph.D)
 
Cv dr-rahul- hajare jan- 2017
Cv  dr-rahul- hajare   jan- 2017Cv  dr-rahul- hajare   jan- 2017
Cv dr-rahul- hajare jan- 2017
Rrahul Hajare (Post Doc., Ph.D)
 
Kamilar Resume
Kamilar ResumeKamilar Resume
Kamilar Resume
Gregg Kamilar
 
Resume
ResumeResume
Dinesh
DineshDinesh
Dinesh
Dinesh kumar
 
Resume
ResumeResume
Resume
DHIRAJ YADAV
 
Vikas res
Vikas resVikas res
Vikas res
Vikas Choudhary
 
CV.pdf
CV.pdfCV.pdf
jitendra_sonar_R___D[2].
jitendra_sonar_R___D[2].jitendra_sonar_R___D[2].
jitendra_sonar_R___D[2].
Jitendra Sonar
 
Tuniki Balaraju_Curriculum Vitae-AUGUST-2016
Tuniki Balaraju_Curriculum Vitae-AUGUST-2016Tuniki Balaraju_Curriculum Vitae-AUGUST-2016
Tuniki Balaraju_Curriculum Vitae-AUGUST-2016
Tuniki Balaraju
 
Sree GLP- Analytical CV 2018
Sree GLP- Analytical CV 2018Sree GLP- Analytical CV 2018
Sree GLP- Analytical CV 2018
SREENIVAS REDDY
 
Sree glp- analytical cv 2018
Sree glp- analytical cv 2018Sree glp- analytical cv 2018
Sree glp- analytical cv 2018
SREENIVAS REDDY
 
Ramabhadra c.v (2)
Ramabhadra c.v (2)Ramabhadra c.v (2)
Ramabhadra c.v (2)
Santosh Rama Bhadra Tata
 

Similar to Dr.GYM-CV (20)

RV-cv-pharm pdf
RV-cv-pharm pdfRV-cv-pharm pdf
RV-cv-pharm pdf
 
CV_Dr R Ghosh
CV_Dr R GhoshCV_Dr R Ghosh
CV_Dr R Ghosh
 
brijesh(2)
brijesh(2)brijesh(2)
brijesh(2)
 
TFadra-Khan Resume
TFadra-Khan ResumeTFadra-Khan Resume
TFadra-Khan Resume
 
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
 
CV_Hari Narayan Kushwaha
CV_Hari Narayan KushwahaCV_Hari Narayan Kushwaha
CV_Hari Narayan Kushwaha
 
Resume....
Resume....Resume....
Resume....
 
Cv dr-rahul- hajare jan- 2017
Cv  dr-rahul- hajare   jan- 2017Cv  dr-rahul- hajare   jan- 2017
Cv dr-rahul- hajare jan- 2017
 
Cv dr-rahul- hajare jan- 2017
Cv  dr-rahul- hajare   jan- 2017Cv  dr-rahul- hajare   jan- 2017
Cv dr-rahul- hajare jan- 2017
 
Kamilar Resume
Kamilar ResumeKamilar Resume
Kamilar Resume
 
Resume
ResumeResume
Resume
 
Dinesh
DineshDinesh
Dinesh
 
Resume
ResumeResume
Resume
 
Vikas res
Vikas resVikas res
Vikas res
 
CV.pdf
CV.pdfCV.pdf
CV.pdf
 
jitendra_sonar_R___D[2].
jitendra_sonar_R___D[2].jitendra_sonar_R___D[2].
jitendra_sonar_R___D[2].
 
Tuniki Balaraju_Curriculum Vitae-AUGUST-2016
Tuniki Balaraju_Curriculum Vitae-AUGUST-2016Tuniki Balaraju_Curriculum Vitae-AUGUST-2016
Tuniki Balaraju_Curriculum Vitae-AUGUST-2016
 
Sree GLP- Analytical CV 2018
Sree GLP- Analytical CV 2018Sree GLP- Analytical CV 2018
Sree GLP- Analytical CV 2018
 
Sree glp- analytical cv 2018
Sree glp- analytical cv 2018Sree glp- analytical cv 2018
Sree glp- analytical cv 2018
 
Ramabhadra c.v (2)
Ramabhadra c.v (2)Ramabhadra c.v (2)
Ramabhadra c.v (2)
 

Dr.GYM-CV

  • 1. Curriculum Vitae Dr. Meti G Y R &D Assistant manager, R L Fine Chem pvt ltd Yelahanka Bangalore Career Objective: To achieve a challenging position in a desired organization, where I can prove my capabilities and strength in conjunction with organization’s goals and objectives. Date of birth 12/10/1971 Age 44 Nationality Indian Marital Status Married Address for correspondence Dr. Gangadhar Y. Meti c/o, Ashwathamma #21, first floor, 2nd B cross Chikkabommasandra, GKVK post Yelahanka new town, Bangalore 560065 E-mail: gymeti@rediffmail.com Dr.gym1971@gmail.com State: Karnataka Mobile: +91-9739422694, +91-8762191241 Job Profile : Having more than 12 years of Experience in Process R&D
  • 2.  R L Fine Chem., Yelahanka, Bangalore working as a R&D Assistant manager (Since Dec 2013)  Dept of Chemistry of Karnataka University Dharwad as a UGC Project fellow (June 2010- Jan 2013)  Jubilant Organosys Ltd. Mysore, worked as a Research Scientist in Process R & D.( Nov 2003 to May 2010)  R L Fine Chem Yelahanka, Bangalore, worked as a R&D Chemist (Feb 2001–Oct 2003).  Recon Ltd Bangalore, worked as a Trainee R&D Chemist. (July 1997-Dec-1997).  Shri Kalidas Composite Pre-University College Badami, worked as a part time Lecturer. (Aug 1998 to Sept 1999) Academic Credentials:  Doctor of Philosophy PhD in Organic Chemistry May 2011-Mar 2015 Karnatak University, Dharwad, India  Junior Research Fellow (JRF) in the UGC funded Major Research Project 2010-2013  Master of Science (M. Sc.) in Chemistry / Organic Chemistry (First Class), from June 1995- May, 1997 Karnatak University, Dharwad, India  Bachelor of Science (B.Sc.) in Chemistry, Physics, Mathematics (Second Class), June 1992 – May 1995, Karnatak University, Dharwad, India.  Post graduate Diploma in IPR (Waiting for marks card, with first class) June 2012- Sept 2015 from K S O University Mysore Research Highlights : I was involved in Synthetic Organic Chemistry Research during my Ph.D. course. Twenty of my research samples have been selected for anti cancer screening (against 60 cancer cell lines) at national cancer Institute, a daughter organization of National Institute of Health, USA. Among these samples, three have been screened for five dose testing level. Responsibilities:  Responsible for planning and executing developmental activities related to improvement in quality/efficiency/process simplification etc., of existing products as well as development of process for new products.  Applied six sigma concepts in the process development of Atomxetine hydrochloride, Paliperidone palmitate, Olmesartan and Azilsartan medoxomil.
  • 3.  Technology transfer from lab scale to kilo/pilot plant scale and commercialization through appropriate validation, scale up and optimization studies.  Developing non-infringing routes for the existing/new molecules.  Online literature search, infringement analysis & suggestion and interpreting the claims in patents.  Updating the literature for the particular project at regular interval.  Interpretation of intermediate/finished product by IR, NMR, Mass, GC and HPLC.  Preparing Development report, Impurity profiling, Technology transfer document and Polymorphs.  Selection of route, Cost reduction, minimization of waste and conforming process norms.  Documentation, safe working and good housekeeping.  Effective co-ordination with process engineering and production department, while transferring the lab developed technologies. Projects Handled:  Antidepressents like Bupropion, Citalopram hydrobromide etc.,  Antipsychotic like Risperidone, paliperidone, Paliperidone palmitate, Ziprasidone.  Antibiotic like Azithromycin.  Antispasmodic like Pinaverium bromide.  Analgesic like Tramadol etc.  Antihistamine like Doxylamine Citrate etc.  Norepinephrine reuptake inhibitor (NRI) or Adrenergic reuptake inhibitor (ARI) like Atomxetine hydrocloride  Antihypertensive like Olmesartan and Azilsartan medoxomil. Training programs:  Safety, Health and Environment training program periodically.  GMP and GLP training program periodically.  Six sigma-Designs of Experiments.  Intellectual property rights (patents only).  Interpersonal relationship. Summary of Skills:  Patent search, Patent analysis, and literature search  Optimization, validation, scale up and Technology transfer  Auto clave reactions and Moisture sensitive reactions
  • 4.  Crystallization techniques  Impurity preparation.  Column chromatography Achievements:  Successfully validated and implemented the “non infringing process route” to commercial plant for Bupropion, Risperidone, Ziprasidone, Azithromycin.  Gained commanding knowledge on Intellectual Property Rights (patents only) Publications:  Synthesis of biphenyl derivatives as ACE and α-amylase inhibitors, Gangadhar Yamanappa Meti, Ravindra Ramappa Kamble, Dharesh Bhimaraya Biradar, Sheetal Babu Margankop, Med. Chem. Res. (Springer), 2013, 22:5868-77.  An efficient synthesis, X-ray and spectral characterization of biphenyl derivatives, G. Y. Meti, R. R Kamble, D. B. Biradar, T. Taj, T. Gireesh, I. M Khazi, S. T. Vaidyanathan, R. Mohandoss, B. Sridhar, and V. Parthasarathy, J. Chem. Sci (Springer) 123, 2011, 393–401.  Synthesis of 4H-pyrido [1,2-a]pyrimidin-4-one derivatives as Anti-inflammatory agents, Gangadhar Meti, Pramod Kattimani, Ravindra Kamble, H. C. Devarajegowda, Mahadev Kumbar, D. Jagadeesh Prasad, World. J. Pharm. Sci. 2015, 3, 277-287.  2-[4-(Morpholin-4-ylmethyl)phenyl]benzonitrile, Gangadhar Y. Meti, R. R Kamble, A. J. Ravi, H. K. Arunkashi and H. C. Devarajegowda, Acta Cryst. 2013, E69, o129.  5-{4-[(5-Benzyl-2H-tetrazol-2-yl)-methyl]biphenyl-2-yl}-1H-tetrazole monohydrate, Gangadhar Y. Meti, S. Jayaseelan, R. R. Kamble, Atukuri Dorababu and H. C. Devarajegowda, Acta Cryst. 2013. E69, o743–o744.  Bis-Tetrazole Derivatives of Biphenyls: Molecular Docking, Synthesis and ACE Inhibition Studies, Gangadhar Y. Meti, Atulkumar A. Kamble, Kuramkote S. Devaraju, Bodhaguru M. Harish and Ravindra R. Kamble, Bioorg. Med. Chem Letters (Elsevier) (Communicated).  Synthesis and anticancer activity of 6-chloro-5-(2-chloroethyl)-1,3-dihydro- 2H-indol-2-one derivatives.E J Medi Che (Communicated). Gangadhar Y. Meti, Ravindra R. Kamble, Pramod P. Kattimani, Atulkumar A. Kamble, T. M. Girish, H. C. Devarajegowda.  Facile Synthesis of novel quinoline derivatives as anticancer agents, S. B. Margankop, R. R. Kamble, J. Hoskeri, D. J. Prasad, G. Y. Meti, Med. Chem. Res. (Springer), DOI No. 10.1007/s00044-013-0855-2.
  • 5.  Synthesis of novel imidazo [2,1-b][1,3,4] thiadiazoles appended to sydnone as anticancer agents, Tegginamath Gireesh, Ravindra R. Kamble, Tasneem Taj, Pramod P. Kattimani, Gangadhar Y. Meti, Med. Chem. Res. (Springer), 2013, 22:4367-75.  Expedient synthesis of benzimidazoles from amides, Pramod P. Kattimani, Ravindra R. Kamble, Gangadhar Y. Meti, RSC.Adv, 2015,5, 29447-29455.  Ring Opening of Tetrazole via Unusual Vilsmeir-Haack Reaction Forming Novel Triazenes. Atukuri Dorababu, Ravindra R. Kamble, H. C. Devarajegowda and Gangadhar Y. Meti. Letters in Organic Chemistry, 2015, 12, 122-128.  Synthesis of Novel 1,2,4-Triazole Derivatives as Antimicrobial Agents via the Japp-Klingemann Reaction: Investigation of Antimicrobial Activities. Journal of Chemistry, (2013), http://dx.doi.org/10.1155/2013/909706,Tasneem Taj, Ravindra R. Kamble, Atukuri Dorababu, and Gangadhar Y. Meti.  Electronic Effect of Substituents Present on Carbonyl Compounds: Analysis of Product Formation in One-Pot Synthesis of 1, 3, 4-thiadiazole Ring. ACSj.18204, Sheetal B. Marganakop, Ravindra R. Kamble, Gangadhar Y. Meti and Mahadev N. Kumbar References: Need basis